Wiener Privatklinik
Wiener Privatklinik
Austria, Vienna
Christoph Zielinski
44 years of experience
accreditations :
Clinic is certified :
Lung cancer stage 4 treatment cost in Austria typically includes essential services like a consultation with an oncologist, which ranges from $200 to $400. Primary treatment interventions, such as stereotaxic radiosurgery, run from $17,000 to $26,000, while complex lung cancer surgery costs $42,000 to $68,000. Total expenses depend on the treatment modality, genetic mutations, and the specific clinic, primarily in Vienna.
Typical Lung Cancer Stage 4 Treatment Costs in Austria
Bookimed Expert Insight: Advanced stage patients requiring personalized medicine should consider Wiener Privatklinik. Their International Oncology Center features board-certified experts like Univ.-Prof. Dr. Wolfgang Köstler. He specializes in targeted cancer therapies and biomarker development for complex cases. International patients benefit from high-tier care in Vienna at JCI-aligned facilities like Döbling Private Hospital. These centers maintain complication rates below nominal values for surgical interventions.
| Turkey | Austria | Spain | |
| Stereotaxic radiosurgery | from $4,500 | from $17,000 | from $12,000 |
| Radiation therapy for colorectal cancer | from $7,000 | from $12,000 | from $10,000 |
| Pneumonectomy | from $10,872 | from $50,000 | from $35,000 |
| Lung cancer surgery | from $17,000 | from $42,000 | from $40,000 |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
Professor Wolfgang Köstler is an internationally recognized oncologist focused on personalized treatments, including immunotherapy and targeted therapies. He integrates these approaches with his long-time academic and research leadership.
The doctor is a leading figure in medical oncology, hematology, and cancer immunotherapy, with a career spanning over four decades. After earning a medical degree from the University of Vienna in the 1970s, the doctor completed specialist training in internal medicine and oncology in the 1980s.
In the 1990s, the doctor was appointed Head of the Clinical Division of Oncology at the Medical University of Vienna, leading Austria's largest oncology department. The 2000s saw the founding of the Comprehensive Cancer Center Vienna, integrating patient care, research, and education.
The doctor served as President of the Central European Cooperative Oncology Group in the 2010s and currently holds positions as Chairman of the Vienna Cancer Center and Medical Director of Wiener Privatklinik’s International Oncology Center.
Austria offers high-standard care for stage 4 lung cancer through specialized institutions like Wiener Privatklinik and Döbling Private Hospital. Modern protocols emphasize molecular profiling and targeted therapies. Leading centers provide advanced immunotherapy and precision radiation within JCI-accredited or ISO-certified facilities located in Vienna.
Bookimed Expert Insight: Data shows that choosing a center like Wiener Privatklinik provides direct access to specialists from the Medical University of Vienna. This bridge between private comfort and academic expertise is vital. Dr. Wolfgang Köstler, for instance, has over 20 years of experience in translational research. This ensures patients receive the latest clinical trial protocols even in a private setting.
Patient Consensus: Patients emphasize that speed is critical. They value centers that complete molecular diagnosis and pathology reports within 8 days to start treatment immediately. Many also highlight the importance of multidisciplinary tumor boards for coordinating complex stage 4 care.
Leading lung cancer specialists in Austria for Stage 4 cases include Dr. Wolfgang Köstler and Prof. Dr. Christoph Zielinski. These experts specialize in genomic-driven therapies and immunotherapy at JCI-accredited facilities in Vienna. Treatment plans often integrate multidisciplinary tumor boards and molecular biomarker testing.
Bookimed Expert Insight: While university centers like AKH Vienna offer deep research access, Wiener Privatklinik provides faster coordination for complex Stage 4 cases. Our data shows this facility integrates over 400 physicians, including many professors from the Medical University of Vienna. This allows patients to access academic-level expertise with significantly shorter waiting times for initial consultations and therapy starts.
Patient Consensus: Patients emphasize the importance of securing full molecular profiling before starting treatment. They often note that seeking a second opinion at a major Viennese center changed their initial palliative plan to a more targeted therapeutic approach.
Austria offers advanced immunotherapies and targeted therapies for stage 4 lung cancer. Specialized centers utilize molecular diagnostics to identify genetic mutations like EGFR and ALK. These personalized treatments help improve 5-year survival rates. Austrian facilities consistently exceed the European average for lung cancer survival.
Bookimed Expert Insight: Quality of care in Vienna is heavily driven by the presence of university-affiliated professors. At Wiener Privatklinik, many of the 400 plus physicians also hold positions at the Medical University of Vienna. This direct link ensures that private patients receive protocols based on the most recent translational cancer research and biomarker developments.
Patient Consensus: Patients emphasize that lung cancer care depends entirely on initial molecular profiling. They note that targeted therapies often provide a better quality of life than traditional options when driver mutations are present.
Austrian oncology centers consider surgery and radiation for Stage 4 lung cancer when localized treatments support systemic therapies. Surgeons and radiation oncologists use these tools for oligometastatic disease. They also address specific symptoms or treat stubborn tumor sites while patients receive immunotherapy.
Bookimed Expert Insight: Patients should focus on clinics with dedicated International Oncology Centers rather than general surgical wards. At Wiener Privatklinik, specialists like Univ. Prof. Dr. Wolfgang Köstler integrate systemic immunotherapies with localized interventions. Our data shows these private institutions report complication rates below nominal values. They often provide faster access to tumor board reviews than large public academic hospitals.
Patient Consensus: Patients note that Stage 4 does not automatically rule out radiation. Many emphasize that Austrian specialists are often willing to reconsider surgery if systemic treatments significantly shrink the primary tumor first.